Adding DA-2811 to standard diabetes treatment
Part of Hormones & metabolism clinical trials.
This study tests whether adding a new medicine called DA-2811 to your current diabetes medicines helps lower blood sugar more effectively in people with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have type 2 diabetes
- Your fasting blood sugar is 270 mg/dL or lower
- Your body mass index (BMI) is between 18.5 and 40
- You are willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new diabetes medication (DA-5218) added to your current metformin treatment to see if it improves blood sugar control safely. It may help you manage your type 2 diabetes better.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests whether adding a sodium-glucose cotransporter-2 inhibitor (SGLT2i), a thiazolidinedione (TZD), or a combination of both to your current DPP4 inhibitor-based treatment can improve blood sugar control in type 2 diabetes. It aims to find the best add-on option for people who need extra help managing their diabetes.
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.